James S. J. Manuso

CIK: 0001236365

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

IRD

Opus Genetics, Inc.

Director

HURA

TuHURA Biosciences, Inc./NV

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

IRD
Opus Genetics, Inc.
Apr 20, 2026
Award(A)
Direct
24.4K shares-
HURA
TuHURA Biosciences, Inc./NV
Feb 12, 2026
Award(A)
Options (Right to Buy)
Direct
156.2K shares-
IRD
Opus Genetics, Inc.
Jan 1, 2026
Award(A)
Direct
31.2K shares-
IRD
Opus Genetics, Inc.
Apr 30, 2025
Award(A)
Direct
79.5K shares-
HURA
TuHURA Biosciences, Inc./NV
Jan 2, 2025
Award(A)
Options (Right to Buy)
Direct
59.6K shares-
IRD
Opus Genetics, Inc.
Jan 2, 2025
Award(A)
Direct
50.2K shares-
KTRA
Kintara Therapeutics, Inc.
Oct 18, 2024
Award(A)
Options (Right to Buy)
Direct
13.6K shares-
KTRA
Kintara Therapeutics, Inc.
Oct 18, 2024
Award(A)
Options (Right to Buy)
Direct
13.6K shares-

		Type	Shares	Price		Ownership
Apr 20, 2026	IRD Opus Genetics, Inc.	Award(A)	24,367	-	$0	Direct
Feb 12, 2026	HURA TuHURA Biosciences, Inc./NV	Award(A) Options (Right to Buy)	156,240	-	-	Direct
Jan 1, 2026	IRD Opus Genetics, Inc.	Award(A)	31,188	-	$0	Direct
Apr 30, 2025	IRD Opus Genetics, Inc.	Award(A)	79,504	-	-	Direct
Jan 2, 2025	HURA TuHURA Biosciences, Inc./NV	Award(A) Options (Right to Buy)	59,590	-	-	Direct
Jan 2, 2025	IRD Opus Genetics, Inc.	Award(A)	50,222	-	$0	Direct
Oct 18, 2024	KTRA Kintara Therapeutics, Inc.	Award(A) Options (Right to Buy)	13,553	-	-	Direct
Oct 18, 2024	KTRA Kintara Therapeutics, Inc.	Award(A) Options (Right to Buy)	13,553	-	-	Direct

1-8 of 8 transactions

About MANUSO JAMES S J

MANUSO JAMES S J (SEC CIK 0001236365) files insider reports with the SEC as Director of Opus Genetics, Inc. (IRD) and Director of TuHURA Biosciences, Inc./NV (HURA).

Signal8 holds 8 ownership filings by MANUSO JAMES S J (1 Form 3, 7 Form 4), filed between Oct 22, 2024 and Apr 22, 2026. Those filings report 8 transactions, from Oct 18, 2024 to Apr 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MANUSO JAMES S J's filings is in DURHAM, NC.

Recent filings by MANUSO JAMES S J

Apr 20, 2026: Grant or award of IRD shares (Form 4, code A).
Feb 12, 2026: Grant or award of HURA derivative securities (Form 4, code A).
Jan 1, 2026: Grant or award of IRD shares (Form 4, code A).
Apr 30, 2025: Grant or award of IRD shares (Form 4, code A).
Jan 2, 2025: Grant or award of HURA derivative securities (Form 4, code A).

Other insiders filing for Opus Genetics, Inc. (IRD)

SCHACHLE JOSEPH K, Chief Operating Officer
YERXA BENJAMIN R, President
Gagnon Robert E., Chief Financial Officer
Magrath George, Chief Executive Officer
Foundation Fighting Blindness Retinal Degeneration Fund, Director
Gallagher Cam, Director

How to read Form 4 transaction codes